Editorโs Pen: Q&A with APDAโs President and CEO, Leslie A. Chambers, about the importance of care partners
APDA President & CEO Leslie A. Chambers answers questions about APDA services and support, with an emphasis on care partners.
New Clinical Use for Gocovri
The Top 5 Concerns for Parkinsonโs Patients During the COVID-19 Pandemic: APDAโs Chief Scientific Officer, Dr. Rebecca Gilbert, shares the five things PD patients are most worried about right now.
American Parkinson Disease Association Awards First Diversity Research Grant
Article highlighting APDAโs 2020-2021 grant announcements, including our first-ever diversity-focused grant
These Environmental Adjustments Can Help You Stay in Your Home Longer
APDAโs Chief Scientific Officer, Dr. Rebecca Gilbert, offers advice about home modifications that can help you stay in your home safely, for longer
Why Vision Problems Can Be a Serious Health Issue for People with Parkinsonโs
APDAโs Chief Scientific Officer, Dr. Rebecca Gilbert, comments on vision problems for people with PD
Parkinsonโs and Exercise
APDAโs Chief Scientific Officer, Dr. Rebecca Gilbert, talks about the benefits of exercise for people with Parkinsonโs disease.
Putting Treatments into Motion
APDA Information & Referral Center medical director Dr. Tao Xie, as well as APDA Midwest Chapter volunteers Roger Halleen and Glenn Peterson weigh in on life with PD.
Bridging the Gaps: More Inclusive Research Needed to Fully Understand Parkinsonโs Disease
APDAโs Dr. Rebecca Gilbert and Dr. David Standaert (chairman of APDAโs Scientific Advisory Board) co-authored a paper about APDAโs first-ever Diversity in Parkinsonโs Disease Research Conference to address the disparities in PD research and care and propose solutions for improvement.
Karate Shows Promise for People With Parkinsonโs
Recent study about the effects of karate on people with PD.
Rebecca Gilbert, AAN 2019 โ Latest developments in the management of Parkinsonโs disease
In conjunction with the American Academy of Neurology (AAN) Annual Meeting, APDAโs Chief Scientific Officer, Dr. Rebecca Gilbert shares her insights on the latest developments and most important advances in the treatment of PD